🏛️ Verified NIH Record • Updated 2025-11-19
"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" (NCT06800404)
"A Phase 2, Open Label, Efficacy and Safety Study of Autologous HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Hope Biosciences Research Foundation
🩺 Plain-English Summary (8th-Grade Level)
This protocol is part of a clinical study to evaluate efficacy and safety of multiple intravenous administrations of HB-adMSCs for the treatment of Multiple Sclerosis.
Who can join: Review the eligibility criteria below.
Location: Hope Biosciences Research Foundation — Sugar Land, Texas
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hope Biosciences Research Foundation — Sugar Land, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Relapsing Remitting Multiple Sclerosis (RRMS)
Explore by condition: All Relapsing Remitting Multiple Sclerosis (RRMS) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.